Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up
Sponsor: ClinAmygate
A PHASE4 clinical study on Corticosteroids and Covid19, this trial is ongoing. The trial is conducted by ClinAmygate and has accumulated 13 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
13 versions recorded-
Nov 2025 — Present [monthly]
Unknown PHASE4
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
-
Mar 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE4
▶ Show 8 earlier versions
-
Dec 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE4
Status: Completed → Active Not Recruiting
-
Feb 2022 — Dec 2022 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2021 — Feb 2022 [monthly]
Recruiting PHASE4
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ClinAmygate
For direct contact, visit the study record on ClinicalTrials.gov .